These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 23006521)
1. Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010. Chen CY; Huang SY; Tsay W; Yao M; Tang JL; Ko BS; Chou WC; Tien HF; Hsueh PR Int J Antimicrob Agents; 2012 Dec; 40(6):533-8. PubMed ID: 23006521 [TBL] [Abstract][Full Text] [Related]
3. Association between incidence of candidaemia and consumption of antifungal agents at a medical centre in Taiwan. Lai CC; Chu CC; Wang CY; Tsai HY; Cheng A; Lee YC; Huang YT; Liao CH; Hsueh PR Int J Antimicrob Agents; 2012 Oct; 40(4):349-53. PubMed ID: 22819796 [TBL] [Abstract][Full Text] [Related]
4. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Wisplinghoff H; Ebbers J; Geurtz L; Stefanik D; Major Y; Edmond MB; Wenzel RP; Seifert H Int J Antimicrob Agents; 2014 Jan; 43(1):78-81. PubMed ID: 24182454 [TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12. Chen CY; Sheng WH; Huang SY; Chou WC; Yao M; Tang JL; Tsay W; Tien HF; Hsueh PR J Antimicrob Chemother; 2015 May; 70(5):1531-8. PubMed ID: 25558079 [TBL] [Abstract][Full Text] [Related]
6. Species distribution and antifungal susceptibility of blood Candida isolates at a tertiary hospital in southern Taiwan, 1999-2006. Chen PL; Lo HJ; Wu CJ; Lee HC; Chang CM; Lee NY; Wang AH; Lin WL; Ko NY; Lee CC; Ko WC Mycoses; 2011 Jul; 54(4):e17-23. PubMed ID: 20028463 [TBL] [Abstract][Full Text] [Related]
7. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797 [TBL] [Abstract][Full Text] [Related]
8. Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern? Oxman DA; Chow JK; Frendl G; Hadley S; Hershkovitz S; Ireland P; McDermott LA; Tsai K; Marty FM; Kontoyiannis DP; Golan Y J Antimicrob Chemother; 2010 Jul; 65(7):1460-5. PubMed ID: 20430790 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550 [TBL] [Abstract][Full Text] [Related]
10. Breakthrough candidaemia caused by phenotypically susceptible Candida spp. in patients with haematological malignancies does not correlate with established interpretive breakpoints. Gamaletsou MN; Daikos GL; Walsh TJ; Perlin DS; Ortigosa CJ; Psaroulaki A; Pagoni M; Argyropoulou A; Nepka M; Perivolioti E; Kotsopoulou M; Perloretzou S; Marangos M; Kofteridis D; Grammatikou M; Goukos D; Petrikkos G; Sipsas NV Int J Antimicrob Agents; 2014 Sep; 44(3):248-55. PubMed ID: 25108876 [TBL] [Abstract][Full Text] [Related]
11. Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis. Posteraro B; De Carolis E; Criscuolo M; Ballanti S; De Angelis G; Del Principe MI; Delia M; Fracchiolla N; Marchesi F; Nadali G; Picardi M; Piccioni AL; Verga L; Candoni A; Busca A; Sanguinetti M; Pagano L; Mycoses; 2020 Sep; 63(9):900-910. PubMed ID: 32531854 [TBL] [Abstract][Full Text] [Related]
12. Changing epidemiology of candidaemia in Australia. Chapman B; Slavin M; Marriott D; Halliday C; Kidd S; Arthur I; Bak N; Heath CH; Kennedy K; Morrissey CO; Sorrell TC; van Hal S; Keighley C; Goeman E; Underwood N; Hajkowicz K; Hofmeyr A; Leung M; Macesic N; Botes J; Blyth C; Cooley L; George CR; Kalukottege P; Kesson A; McMullan B; Baird R; Robson J; Korman TM; Pendle S; Weeks K; Liu E; Cheong E; Chen S; J Antimicrob Chemother; 2017 Apr; 72(4):1103-1108. PubMed ID: 28364558 [TBL] [Abstract][Full Text] [Related]
13. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR]. Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074 [TBL] [Abstract][Full Text] [Related]
14. Changing epidemiology of candidemia in a medical center in middle Taiwan. Hii IM; Chang HL; Lin LC; Lee YL; Liu YM; Liu CE; Chen CH; Cheng YR; Chang CY J Microbiol Immunol Infect; 2015 Jun; 48(3):306-15. PubMed ID: 24113067 [TBL] [Abstract][Full Text] [Related]
15. A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies. Gamaletsou MN; Walsh TJ; Zaoutis T; Pagoni M; Kotsopoulou M; Voulgarelis M; Panayiotidis P; Vassilakopoulos T; Angelopoulou MK; Marangos M; Spyridonidis A; Kofteridis D; Pouli A; Sotiropoulos D; Matsouka P; Argyropoulou A; Perloretzou S; Leckerman K; Manaka A; Oikonomopoulos P; Daikos G; Petrikkos G; Sipsas NV Clin Microbiol Infect; 2014 Jan; 20(1):O50-7. PubMed ID: 23889746 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital. Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259 [TBL] [Abstract][Full Text] [Related]
17. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland. Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J; Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136 [TBL] [Abstract][Full Text] [Related]